• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于预后相关 RNA 结合蛋白构建和验证食管癌预后模型

Construction and validation of a prognostic model for esophageal cancer based on prognostic-related RNA-binding protein.

机构信息

Department of Laboratory Medicine, The First People's Hospital of Kashi, Kashi City, China.

The First People's Hospital of Kashi, Kashi City, China.

出版信息

Medicine (Baltimore). 2024 Sep 13;103(37):e39639. doi: 10.1097/MD.0000000000039639.

DOI:10.1097/MD.0000000000039639
PMID:39287291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404941/
Abstract

BACKGROUND

Construction of a prognostic model for esophageal cancer (ESCA) based on prognostic RNA-binding proteins (RBPs) and preliminary evaluation of RBP function.

METHODS

RNA-seq data of ESCA was downloaded from The Cancer Genome Atlas database and mRNA was extracted to screen differentially expressed genes using R. After screening RBPs in differentially expressed genes, R packages clusterProfiler and pathview were used to analyze the RBPs for Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway. Based on the prognosis-related RBPs, COX regression was used to establish the prognostic risk model of ESCA. Risk model predictive ability was assessed using calibration analysis, receiver operating characteristic curves, Kaplan-Meier curves, decision curve analysis, and Harrell consistency index (C-index). A nomogram was established by combining the risk model with clinicopathological features.

RESULTS

A total of 105 RBPs were screened from ESCA. A prognostic risk model consisting of 6 prognostic RBPs (ARHGEF28, BOLL, CIRBP, DKC1, SNRPB, and TRIT1) was constructed by COX regression analysis. The prognosis was worse in the high-risk group, and the receiver operating characteristic curve showed (area under the curve = 0.90) that the model better predicted patients' 5-year survival. In addition, 6 prognostic RBPs had good diagnostic power for ESCA. In addition, a total of 39 mRNAs were identified as predicted target molecules for DKC1.

CONCLUSION

ARHGEF28, BOLL, CIRBP, DKC1, SNRPB, and TRIT1, as RBPs, are associated with the prognosis of ESCA, which may provide new ideas for targeted therapy of ESCA.

摘要

背景

基于预后 RNA 结合蛋白(RBPs)构建食管癌(ESCA)预后模型,并初步评估 RBP 功能。

方法

从癌症基因组图谱数据库下载 ESCA 的 RNA-seq 数据,并提取 mRNA,使用 R 筛选差异表达基因。筛选差异表达基因中的 RBPs 后,使用 R 包 clusterProfiler 和 pathview 分析 RBPs 的基因本体论富集和京都基因与基因组百科全书通路。基于与预后相关的 RBPs,使用 COX 回归建立 ESCA 的预后风险模型。通过校准分析、接受者操作特征曲线、Kaplan-Meier 曲线、决策曲线分析和 Harrell 一致性指数(C 指数)评估风险模型的预测能力。通过结合风险模型和临床病理特征建立列线图。

结果

从 ESCA 中筛选出 105 个 RBPs。通过 COX 回归分析构建了由 6 个预后 RBPs(ARHGEF28、BOLL、CIRBP、DKC1、SNRPB 和 TRIT1)组成的预后风险模型。高风险组的预后较差,接受者操作特征曲线显示(曲线下面积=0.90),该模型能更好地预测患者的 5 年生存率。此外,6 个预后 RBPs 对 ESCA 具有良好的诊断能力。此外,共鉴定出 39 个 mRNAs 作为 DKC1 的预测靶分子。

结论

ARHGEF28、BOLL、CIRBP、DKC1、SNRPB 和 TRIT1 作为 RBPs 与 ESCA 的预后相关,这可能为 ESCA 的靶向治疗提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/f0c943e63dc2/medi-103-e39639-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/a9e7627db351/medi-103-e39639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/af24f63d0838/medi-103-e39639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/979185f0ce92/medi-103-e39639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/d9bab080f1af/medi-103-e39639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/96951fd16831/medi-103-e39639-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/4b98d8f4e1f2/medi-103-e39639-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/d63b6005ffeb/medi-103-e39639-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/da6d9ed81513/medi-103-e39639-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/f0c943e63dc2/medi-103-e39639-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/a9e7627db351/medi-103-e39639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/af24f63d0838/medi-103-e39639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/979185f0ce92/medi-103-e39639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/d9bab080f1af/medi-103-e39639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/96951fd16831/medi-103-e39639-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/4b98d8f4e1f2/medi-103-e39639-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/d63b6005ffeb/medi-103-e39639-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/da6d9ed81513/medi-103-e39639-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b0/11404941/f0c943e63dc2/medi-103-e39639-g009.jpg

相似文献

1
Construction and validation of a prognostic model for esophageal cancer based on prognostic-related RNA-binding protein.基于预后相关 RNA 结合蛋白构建和验证食管癌预后模型
Medicine (Baltimore). 2024 Sep 13;103(37):e39639. doi: 10.1097/MD.0000000000039639.
2
Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.基于RNA结合蛋白的食管癌患者预后模型的建立与验证
J Thorac Dis. 2023 Nov 30;15(11):6178-6191. doi: 10.21037/jtd-23-1307. Epub 2023 Nov 27.
3
The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.构建和验证与 RNA 结合蛋白相关的膀胱癌预后模型。
BMC Cancer. 2021 Mar 8;21(1):244. doi: 10.1186/s12885-021-07930-5.
4
Development of a model to predict the prognosis of esophageal carcinoma based on autophagy-related genes.基于自噬相关基因的食管癌预后预测模型的建立。
Future Oncol. 2022 Feb;18(6):701-717. doi: 10.2217/fon-2021-0070. Epub 2022 Jan 20.
5
A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.一种新型的 RNA 结合蛋白风险特征,可用于预测胶质母细胞瘤患者的预后。
Medicine (Baltimore). 2021 Dec 3;100(48):e28065. doi: 10.1097/MD.0000000000028065.
6
Development of biomarker signatures associated with anoikis to predict prognosis in patients with esophageal cancer: An observational study.开发与失巢凋亡相关的生物标志物特征,以预测食管癌患者的预后:一项观察性研究。
Medicine (Baltimore). 2024 Oct 4;103(40):e39745. doi: 10.1097/MD.0000000000039745.
7
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.开发和验证与 RNA 结合蛋白相关的肝细胞癌预后模型。
BMC Cancer. 2020 Nov 23;20(1):1136. doi: 10.1186/s12885-020-07625-3.
8
Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.RNA 结合蛋白相关预后模型在肾细胞癌中的综合分析。
Int J Med Sci. 2021 Jan 1;18(4):953-963. doi: 10.7150/ijms.50704. eCollection 2021.
9
Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.基于统计分析构建新型膀胱癌 mRNA 特征预测预后模型。
BMC Cancer. 2021 Jul 27;21(1):858. doi: 10.1186/s12885-021-08611-z.
10
Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.基于长链非编码 RNA 的列线图识别可改善食管鳞癌预后预测。
Aging (Albany NY). 2020 Jan 24;12(2):1512-1526. doi: 10.18632/aging.102697.

引用本文的文献

1
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer.食管癌中一种预后性RNA结合蛋白特征的全基因组分析
Transl Cancer Res. 2025 Feb 28;14(2):1428-1446. doi: 10.21037/tcr-2024-2561. Epub 2025 Feb 26.

本文引用的文献

1
Screening of potential key genes in esophageal cancer based on RBP and expression verification of HENMT1.基于 RBP 的食管癌潜在关键基因筛选及 HENMT1 的表达验证。
Medicine (Baltimore). 2023 Dec 8;102(49):e36544. doi: 10.1097/MD.0000000000036544.
2
Esophageal cancer: emerging therapeutics.食管癌:新兴治疗方法。
Expert Opin Ther Targets. 2022 Feb;26(2):107-117. doi: 10.1080/14728222.2022.2036718. Epub 2022 Feb 12.
3
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
4
SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer.SNRPB 是顺铂诱导非小细胞肺癌细胞应答的介质。
Med Oncol. 2021 Apr 9;38(5):57. doi: 10.1007/s12032-021-01502-0.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.SNRPB 介导的 RNA 剪接促进肝癌细胞增殖和干性。
Aging (Albany NY). 2020 Dec 3;13(1):537-554. doi: 10.18632/aging.202164.
7
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
8
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.肺腺癌 RNA 结合蛋白相关预后模型的建立与验证。
Aging (Albany NY). 2020 Feb 22;12(4):3558-3573. doi: 10.18632/aging.102828.
9
miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.miR-196b-5p 下调 TSPAN12 和 GATA6 促进非小细胞肺癌的肿瘤进展。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4347-4357. doi: 10.1073/pnas.1917531117. Epub 2020 Feb 10.
10
The RNA-binding protein HuR is a negative regulator in adipogenesis.RNA 结合蛋白 HuR 是脂肪生成中的负调控因子。
Nat Commun. 2020 Jan 10;11(1):213. doi: 10.1038/s41467-019-14001-8.